Very few investors will look back on 2022 fondly, with the S&P 500 average down 19.4% and the Dow Jones Industrial Average down 8.9%. Even healthcare stocks (which generally weather economic downturns well) are down this year, with the Fidelity MSCI Healthcare ETF down roughly 6.8% in 2022.
Some healthcare stocks, though, did manage to buck the downturn trend and are doing well despite the market doldrums. That doesn't guarantee they will continue to do well in 2023, but TransMedics Group (NASDAQ: TMDX) , Vertex Pharmaceuticals (NASDAQ: VRTX) , and AstraZeneca (NASDAQ: AZN) all have the pieces in place to continue their share gains into the new year.
Let's take a closer look at these three healthcare stocks defying the current bear market.
For further details see:
3 Top Healthcare Stocks Defying the Bear Market